FAS and COVID-19: Therefore, additional studies in other population strata with different genetic characteristics and the evaluation of variations in other genes in the apoptosis pathway could complement the understanding of the relevance of polymorphisms in the FAS and FASL genes in the development of COVID-19 manifestations and their potential use as a biomarker of disease progression.